Mutational Activation of the K-rasOncogene
- 8 October 1987
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 317 (15), 929-935
- https://doi.org/10.1056/nejm198710083171504
Abstract
To define the role of cellular oncogenes in human cancers, we studied the prevalence of mutational activation of ras oncogenes in untreated non-small-cell lung cancer. Genomic DNA was extracted from 39 tumor specimens obtained by thoracotomy and was examined for activating point mutations in codons 12, 13, and 61 of the H-ras, K-ras, and N-ras genes. A novel, highly sensitive assay based on oligonucleotide hybridization following an in vitro amplification step was employed.This publication has 34 references indexed in Scilit:
- Prevalence of ras gene mutations in human colorectal cancersNature, 1987
- Rapid Prenatal Diagnosis of Sickle Cell Anemia by a New Method of DNA AnalysisNew England Journal of Medicine, 1987
- Mutagens, oncogenes and cancerTrends in Genetics, 1986
- c-K-ras codon 12 GGT-CGT point mutation an infrequent event in human lung cancerBiochemical and Biophysical Research Communications, 1986
- Gene Amplification of c- myc and N- myc in Small Cell Carcinoma of the LungScience, 1986
- Oncogenes Amplified in Cancer CellsScience, 1984
- Amplification and expression of the c-myc oncogene in human lung cancer cell linesNature, 1983
- Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1Nature, 1983
- Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cellsNature, 1982
- Detection of specific sequences among DNA fragments separated by gel electrophoresisJournal of Molecular Biology, 1975